Searchable abstracts of presentations at key conferences in endocrinology

ea0055p01 | Poster Presentations | SFEEU2018

A case of primary aldosteronism and Hashimoto’s thyroiditis – complicated relationship or pure coincidence?

Samarasinghe Suhaniya , Martineau Marcus

Aldosterone is a steroidal hormone that specifically binds to the mineralocorticoid receptor (MR). Production and secretion of aldosterone is triggered by changes in blood pressure (BP). Primary aldosteronism (PA) is an important cause of secondary hypertension. The effects of aldosterone have been described in renal and vascular tissue but recent studies have shown that MR is also expressed in non- epithelial cells such as those of the immune system. A 29-year-old Afro-Carrib...

ea0018p3 | (1) | MES2008

A genetic cause for primary amenorrhoea

Martineau Marcus , Haq Masud

Primary Amenorrhoea is usually the result of a genetic or anatomical abnormality. Androgen insensitivity syndrome (AIS) is an uncommon cause in which individuals with a 46XY male karyotype are resistant to testosterone due to a defect of the androgen receptor.A 16-year-old female of non-consanguineous parents presented with primary amenorrhoea. There was no family history of delayed puberty. She was of normal female appearance (height 5′9″, B...

ea0055we13 | Workshop E: Disorders of the adrenal gland | SFEEU2018

Primary hyperaldosteronism presenting following a miscarriage

Thurston Layla , Qureshi Sheharyar , Martineau Marcus

Case history: A 35-year-old female was found to be significantly hypertensive (181/91 mmHg) following a first trimester miscarriage (at 8 weeks gestation) during her first pregnancy.Investigations: Blood tests demonstrated moderate hypokalaemia (2.6 mmol/l) with a normal serum sodium (140 mmol/l) and eGFR (>90 ml/min). ECG showed hypokalaemic changes with prolongation of the PR interval and T wave flattening. To avoid potential misinterpretation, add...

ea0050ep027 | Bone and Calcium | SFEBES2017

Resistance to 1 hydroxyvitamin D? A challenging case

Zaman Shamaila , Aziz Umaira , Qureshi Sheharyar , Falinska Agnieszka , Martineau Marcus

Hypoparathyroidism following parathyroidectomy is commonly treated with activated vitamin D, (alfacalcidol and calcitriol). Alfacalcidol (1-hydroxyvitamin D) is converted by hepatic 25-hydroxylase to generate calcitriol (1,25-dihydroxyvitamin D) to act on target cells.We present the case of 66 year old man who was admitted with chest pain in November 2016 and found to have corrected calcium of 1.5 mmol/litre and PO4 2.7 mmol/litre....

ea0050ep027 | Bone and Calcium | SFEBES2017

Resistance to 1 hydroxyvitamin D? A challenging case

Zaman Shamaila , Aziz Umaira , Qureshi Sheharyar , Falinska Agnieszka , Martineau Marcus

Hypoparathyroidism following parathyroidectomy is commonly treated with activated vitamin D, (alfacalcidol and calcitriol). Alfacalcidol (1-hydroxyvitamin D) is converted by hepatic 25-hydroxylase to generate calcitriol (1,25-dihydroxyvitamin D) to act on target cells.We present the case of 66 year old man who was admitted with chest pain in November 2016 and found to have corrected calcium of 1.5 mmol/litre and PO4 2.7 mmol/litre....

ea0050p322 | Obesity and Metabolism | SFEBES2017

Cholestatic pregnancy alters the gut incretin response to diet, affecting GLP-1, PYY and FGF19 secretion, with reversal of changes associated with ursodeoxycholic acid treatment

Ovadia Caroline , Chambers Jenny , Martineau Marcus , Murphy Kevin , Walters Julian , Williamson Catherine

Introduction: Intrahepatic cholestasis of pregnancy (ICP) is characterised by maternal pruritus and raised serum bile acids, and is associated with adverse fetal outcomes (e.g. preterm birth, neonatal unit admission and stillbirth). Maternal metabolic impacts include higher rates of gestational diabetes mellitus, hypertriglyceridaemia and hypercholesterolaemia. Glucose and lipid metabolism are influenced by gut incretin release, and bile acids are ...

ea0050p322 | Obesity and Metabolism | SFEBES2017

Cholestatic pregnancy alters the gut incretin response to diet, affecting GLP-1, PYY and FGF19 secretion, with reversal of changes associated with ursodeoxycholic acid treatment

Ovadia Caroline , Chambers Jenny , Martineau Marcus , Murphy Kevin , Walters Julian , Williamson Catherine

Introduction: Intrahepatic cholestasis of pregnancy (ICP) is characterised by maternal pruritus and raised serum bile acids, and is associated with adverse fetal outcomes (e.g. preterm birth, neonatal unit admission and stillbirth). Maternal metabolic impacts include higher rates of gestational diabetes mellitus, hypertriglyceridaemia and hypercholesterolaemia. Glucose and lipid metabolism are influenced by gut incretin release, and bile acids are ...

ea0065p181 | Metabolism and Obesity | SFEBES2019

The progesterone metabolite epiallopregnanolone sulphate induces glucose-stimulated insulin secretion from human and mouse islets and is reduced in gestational diabetes mellitus

Fan Hei Man , Bellafante Elena , Mitchell Alice , Ovadia Caroline , Martineau Marcus , Jones Peter , McCance David , Marschall Hanns-Ulrich , Hunt Kate , Bewick Gavin , Bowe James , Williamson Catherine

Serum concentrations of progesterone sulphates are raised in intrahepatic cholestasis of pregnancy (ICP), the commonest pregnancy-specific liver disease. Women with ICP have increased rates of gestational diabetes mellitus (GDM). We hypothesised that raised progesterone sulphates may modulate glucose homeostasis. Progesterone sulphates were assayed in serum samples from participants of the hyperglycaemia and adverse pregnancy outcomes (HAPO) study (n=79–94), and ...